Arbutus Biopharma (ABUS)

P/S ratio as of December 2025 (TTM): 62.2

According to Arbutus Biopharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 11.7. At the end of 2025 the company had a P/S ratio of 57.9.

P/S ratio history for Arbutus Biopharma from 2008 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	57.9	-41.28%
2024	98.6	326.52%
2023	23.1	147.34%
2022	9.34	-81.94%
2021	51.7	18.69%
2020	43.6	45.52%
2019	30.0	-18.67%
2018	36.8	41.76%
2017	26.0	-71.16%
2016	90.1	823.01%
2015	9.76	-57.05%
2014	22.7	131.77%
2013	9.81	93.72%
2012	5.06	369.34%
2011	1.08	-52.64%
2010	2.28	-37.33%
2009	3.63	141.78%
2008	1.50

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
NRC Health NRC	3.15	-94.94%	🇺🇸 USA
Nymox Pharmaceutical NYMX	N/A	N/A	Bahamas

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Arbutus Biopharma (ABUS)

P/S ratio as of December 2025 (TTM): 62.2